PortfoliosLab logoPortfoliosLab logo
MFIN vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MFIN vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medallion Financial Corp. (MFIN) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MFIN achieves a -0.63% return, which is significantly lower than NVS's 16.71% return. Over the past 10 years, MFIN has underperformed NVS with an annualized return of 7.54%, while NVS has yielded a comparatively higher 10.49% annualized return.


MFIN

1D
-1.58%
1M
-1.78%
6M
-0.63%
YTD
-0.63%
1Y
3.25%
3Y*
4.58%
5Y*
7.43%
10Y*
7.54%
ALL TIME*
4.55%

NVS

1D
-1.45%
1M
-2.35%
6M
8.22%
YTD
16.71%
1Y
39.55%
3Y*
18.79%
5Y*
15.30%
10Y*
10.49%
ALL TIME*
9.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$315.01K$330.89K$770.92K
$287.25M$275.96M$277.92M

MFIN vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MFIN
Medallion Financial Corp.
-0.63%15.09%0.15%43.96%28.37%18.37%-32.60%55.01%32.86%16.89%
NVS
Novartis AG
16.71%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between MFIN and NVS is 0.17, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.17

Correlation (3Y)
Balances recent behavior with more history.

0.11

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.11

Correlation (10Y)
Provides a long-term view across more market conditions.

0.11

Correlation (All Time)
Calculated using the full available price history since Nov 7, 1996

0.14

Fundamentals

Market Cap

MFIN:

$229.74M

NVS:

$296.80B

EPS

MFIN:

$1.47

NVS:

$6.63

PE Ratio

MFIN:

6.78

NVS:

23.56

PEG Ratio

MFIN:

853.48

NVS:

1.59

PS Ratio

MFIN:

0.71

NVS:

5.40

PB Ratio

MFIN:

0.59

NVS:

7.19

Total Revenue (TTM)

MFIN:

$340.98M

NVS:

$55.63B

Gross Profit (TTM)

MFIN:

$204.51M

NVS:

$41.41B

EBITDA (TTM)

MFIN:

$144.41M

NVS:

$22.26B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MFIN vs. NVS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MFIN
MFIN Risk / Return Rank: 4646
Overall Rank
MFIN Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
MFIN Sortino Ratio Rank: 4242
Sortino Ratio Rank
MFIN Omega Ratio Rank: 4141
Omega Ratio Rank
MFIN Calmar Ratio Rank: 4848
Calmar Ratio Rank
MFIN Martin Ratio Rank: 4949
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8989
Overall Rank
NVS Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 8989
Sortino Ratio Rank
NVS Omega Ratio Rank: 8787
Omega Ratio Rank
NVS Calmar Ratio Rank: 8989
Calmar Ratio Rank
NVS Martin Ratio Rank: 8686
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MFIN vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medallion Financial Corp. (MFIN) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MFINNVSDifference
Sharpe ratioReturn per unit of total volatility

-1.85

Sortino ratioReturn per unit of downside risk

-2.33

Omega ratioGain probability vs. loss probability

1.04

1.33

-0.29

Calmar ratioReturn relative to maximum drawdown

0.10

3.29

-3.19

Martin ratioReturn relative to average drawdown

0.29

7.73

-7.45

MFIN vs. NVS - Sharpe Ratio Comparison

The current MFIN Sharpe Ratio is 0.08, which is lower than the NVS Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of MFIN and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MFIN vs. NVS - Drawdown Comparison

The maximum MFIN drawdown since its inception was -90.32%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for MFIN and NVS.


Loading charts...

Drawdown Indicators


MFINNVSDifference

Max Drawdown

Largest peak-to-trough decline

-90.32%

-42.10%

-48.22%

Max Drawdown (1Y)

Largest decline over 1 year

-24.95%

-12.65%

-12.30%

Max Drawdown (3Y)

Largest decline over 3 years

-37.10%

-19.95%

-17.15%

Max Drawdown (5Y)

Largest decline over 5 years

-41.06%

-20.42%

-20.64%

Max Drawdown (10Y)

Largest decline over 10 years

-82.99%

-26.03%

-56.96%

Current Drawdown

Current decline from peak

-10.00%

-4.58%

-5.42%

Average Drawdown

Average peak-to-trough decline

-43.19%

-10.90%

-32.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.87%

5.38%

+3.49%

Volatility

MFIN vs. NVS - Volatility Comparison

The current volatility for Medallion Financial Corp. (MFIN) is 6.35%, while Novartis AG (NVS) has a volatility of 7.89%. This indicates that MFIN experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MFINNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.35%

7.89%

-1.54%

Volatility (6M)

Calculated over the trailing 6-month period

20.92%

16.05%

+4.87%

Volatility (1Y)

Calculated over the trailing 1-year period

30.83%

21.74%

+9.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.29%

19.28%

+22.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.49%

19.73%

+39.76%

Dividends

MFIN vs. NVS - Dividend Comparison

MFIN's dividend yield for the trailing twelve months is around 5.03%, more than NVS's 3.06% yield.


PositionTTM20252024202320222021202020192018201720162015
MFIN
Medallion Financial Corp.
5.03%4.57%4.37%3.45%4.48%0.00%0.00%0.00%0.00%0.00%19.87%14.06%
NVS
Novartis AG
3.06%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

MFIN vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Medallion Financial Corp. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

MFIN vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between Medallion Financial Corp. and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

MFIN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Medallion Financial Corp. reported a gross profit of 0.00 and revenue of 84.38M. Therefore, the gross margin over that period was 0.0%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a gross profit of 10.74B and revenue of 14.42B. Therefore, the gross margin over that period was 74.5%.

MFIN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Medallion Financial Corp. reported an operating income of 0.00 and revenue of 84.38M, resulting in an operating margin of 0.0%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported an operating income of 4.74B and revenue of 14.42B, resulting in an operating margin of 32.8%.

MFIN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Medallion Financial Corp. reported a net income of 7.45M and revenue of 84.38M, resulting in a net margin of 8.8%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a net income of 3.27B and revenue of 14.42B, resulting in a net margin of 22.7%.


Frequently Asked Questions


MFIN and NVS have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVS has higher volatility (7.89%) compared to MFIN (6.35%). In terms of maximum drawdown, MFIN dropped -90.32% vs NVS's -42.10%.

NVS currently has the higher Sharpe Ratio (1.93 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MFIN and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer